MedTrace Logo

Rare and Atypical Diabetes Network

NCT05544266 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 2000

Last updated 2025-08-14

No results posted yet for this study

Summary

RADIANT is a network of 14 clinical sites and several laboratories dedicated to the study of atypical diabetes.

The objective of this study is to define new forms of diabetes and the unique mechanisms underlying these forms of atypical diabetes. The specific aims are to:

1. Identify and enroll individuals and families with undiagnosed rare and atypical forms of diabetes.
2. Determine the etiologic basis of the metabolic disorder among individuals and families with novel forms of rare and atypical diabetes.
3. Understand the pathophysiology of individuals and families with novel forms of rare and atypical forms of diabetes.

Conditions

  • Diabetes Mellitus
  • Diabetes Mellitus Progression
  • Glucose Intolerance
  • Glucose Metabolism Disorders
  • Metabolic Disease
  • Endocrine; Complications
  • Endocrine System Diseases

Sponsors & Collaborators

  • National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)

    collaborator NIH

  • University of South Florida

    lead OTHER

Principal Investigators

  • Jeffrey Krischer, PhD · University of South Florida

Eligibility

Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2020-09-30
Primary Completion
2030-09-30
Completion
2030-09-30

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05544266 on ClinicalTrials.gov